4527.T
4527.T
JP3982400008
ROHTO PHARMACEUTICAL CO
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
607.09B EUR
526.5B EUR
559.37B EUR
Enterprise Value
600.82B EUR
526.5B EUR
532.8B EUR
Valuation Multiples
Trailing P/E
19.18x
--
--
Forward P/E
16.12x
--
--
Price to Sales
1.72x
--
--
Price to Book
1.97x
--
1.85x
EV/Revenue
1.7x
--
--
EV/EBITDA
9.84x
--
--
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
--
--
--
ende